Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2012; 18(36): 5072-5077
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5072
Table 1 Baseline characteristics of the 163 patients
CharacteristicValue
Age (yr), median (range)60 (30-81)
Male/female, n98/65
Stage, n
I23
II67
III64
IV9
Follow-up duration (d), median (range)756 (419-1355)
Recurrence, n25
Death, n3
Table 2 The maximum standardized uptake value and clinicopathologic characteristics
SUVmax < 8.6 (n = 80)SUVmax8.6 (n = 83)P value
Age (yr), median (range)61.0 (37-81)60.0 (30-81)0.799
Sex (male), n47510.872
Stage, n0.346
I158
II3334
III2836
IV45
Tumor size (cm), median (range)4.0 (2-13.5)4.5 (2.4-9.5)0.02
T stage, n0.01
153
2128
35957
4415
N stage, n0.955
04744
11724
21615
M stage, n0.562
07678
145
Histology0.54
WD67
MD7167
PD4
Mucinous35
Median follow-up (d)7767560.285
Recurrence, n14110.509
Death, n210.547
Table 3 Two-year disease-free survival according to the Kaplan-Meier method
VariableNo. of patientsTwo-year DFS (%)Log-rank P
Age (yr)0.29
≥ 608190.1
< 608285.4
Sex0.08
Male9883.7
Female6593.8
TNM stage < 0.01
I23100
II6798.5
III6478.1
IV944.4
SUVmax0.53
≥ 8.68386.7
< 8.68088.8
CEA (ng/mL) < 0.01
> 53672.2
≤ 512393.5
Table 4 Multivariate Cox regression analysis of disease-free survival
VariableRelative risk95% CIP value
SUVmax ≥ 8.60.80.35-2.160.76
T stage (T3, T4)3.10-6.60.94
N stage (N2)9.782.01-49.50.01
M stage (M1)2.510.78-7.980.12
Age ≥ 60 yr0.60.35-2.160.35
Male1.90.71-5.150.20
CEA > 5 ng/mL3.21.26-8.420.02